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Abstract 
Rose hips have long been used in human diets as a food ingredient and supplement. 
Their multiple medical properties, which have been attributed to their abundant 
carotenoid composition, have attracted widespread scientific attention. This thesis 
examined the carotenoid composition in rose hips from five rose species. The anti-
cancer effect of different carotenoid fractions from rose hips was investigated in human 
breast cancer cell lines, using the natural variation in carotenoid content in hips from 
different rose species. Based on the results obtained, representative single carotenoids 
were selected for further investigation. 
A rapid, effective method was developed using a HPLC-DAD-APCI+-MS system for 
carotenoid identification and quantification in rose hips. Twenty-one carotenoids, 
including 11 xanthophylls and 10 carotenes, were detected in saponified extract and 23 
carotenoid esters in unsaponified extract from hips of the five rose species. Three 
fractions were subsequently isolated from total carotenoid extract of rose hips and their 
anti-proliferative activities were investigated in human breast cancer cell lines. 
Xanthophyll ester fraction was proved more potent than lycopene isomer or an 
undefined carotene fraction. Rosa multiflora Thunb. hips were the most effective, 
giving low IC50 values in MTT assay, and a unique xanthophyll ester pattern was found 
in this species. 
When xanthophyll ester was combined with triterpenes in MTT assay, synergistic 
effects were found in the MCF-7 cancer cell line. A significant synergistic effect was 
also found on combining a 10 µM concentration of rose hip triterpene fraction with 50 
µM ascorbate, which resulted in strong inhibition in cell proliferation in MCF-7 cell 
line, while normal-like cells MCF-10A were relatively undamaged.  
Xanthophyll esters were verified to be more effective than free xanthophylls in MTT 
assay comparing lutein and zeaxanthin with their esters. The xanthophyll ester fraction 
from R. multiflora and individual xanthophyll esters were found to decrease cancer 
stem cell sub-populations and inhibit cell migration. Xanthophyll esters were suggested 
to affect breast cancer cells by a mechanism involving the NF-κB pathway.  
Overall, these results support the beneficial health effects of rose hips and reveal 
potential to involve xanthophyll esters in future breast cancer therapy.   
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1 Introduction 
1.1 Rose hips 
Rose hips, also called rose haws or rose heps, are the fruit of the rose plant 
(Figure 1). The typical colour of rose hips is orange to red, but it ranges from 
dark purple to black in some species. Rose hips are commonly used as herbal 
tea and to make jam, jelly, marmalade, and rose hip wine. An oil is also 
extracted from the seeds. Rose hip soup (nyponsoppa) is an especially popular 
drink in Sweden. A traditional fruit brandy (pálinka) made from rose hips is 
popular in Hungary, Romania and other countries sharing an Austro-Hungarian 
history. Rose hips are also used as the central ingredient of cockta, the fruity-
tasting national soft drink of Slovenia.  
Figure 1. (A) Rosa rubiginosa L. bush and (B) rose hips. Photos: L. Zhong. 
1.1.1 Origin, history and cultivation of the rose plant 
Roses belong to the genus Rosa, in the family Rosaceae. Most species are 
native to Asia, with smaller numbers native to Europe, North America and 
north-west Africa. There are more than 100 species in the Rosa genus growing 
in temperate and subtropical climates of the Northern hemisphere. For over 
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4700 years, roses have been used mainly for ornamental purposes, but also for 
cosmetic and medical purposes (Gustavsson, 1998). 
Rose bushes require relatively low levels of horticultural maintenance. The 
fruit is a potentially profitable crop for the food and nutraceutical industries. In 
the food industry, rose hips from dogrose (Rosa canina L.) have a long 
tradition of use in various types of foods around the world (Werlemark & 
Nybom, 2010). However, many of the rose hips used today for commercial 
products are still collected from the wild, as traditional rose breeding 
objectives have mainly focused on cut flower properties, including 
productivity, postharvest life and increased fragrance, but not on rose hip 
production (Gudin, 2000). The first commercial rose hip plantations in 
southern Sweden were established in the mid-1980s, primarily using superior 
selections mainly of the species Rosa dumalis Bechst. and Rosa rubiginosa L. 
which were chosen based on yield, disease resistance, fruit quality (e.g. high 
content of ascorbic acid, total antioxidants, high level of dry matter) and their 
suitability for mechanical harvesting (Uggla, 2004; Uggla & Nybom, 1996). 
Since the 1990s, Kovács and co-workers in Hungary have evaluated the 
physical and phytochemical characteristics of rose hips from a series of native 
Hungarian rose species for commercial rose hip production and future rose hip 
breeding (Kovács et al., 2010; Kovacs et al., 1999). However, commercial rose 
hip breeding has not been developed widely to date.  
1.1.2 Health properties of rose hips 
Rose hips contain abundant phytochemicals, including phenolics, flavonoids, 
tocopherols, fatty acids, and triterpene acids, with especially large amounts of 
ascorbate (vitamin C), and carotenoids (Zhong et al., 2016; Wenzig et al., 
2008; Olsson et al., 2004). Various phytochemicals in rose hips have 
antioxidant activity and can act as scavengers of reactive oxygen species 
(ROS) (Barros et al., 2010).  
Rose hips have long been used in traditional folk medicine, but their 
multiple health properties have drawn more attention and have been 
investigated more frequently in recent decades. The British Herbal 
Pharmacopoeia reports that rose hips can be used for gastritis, diarrhoea, 
polydipsia, and vitamin C deficiency (Pharmacopoeia, 1983). In both 
laboratory and pre-clinical trials, rose hips have been found to have anti-
inflammatory activity, which has been attributed to high concentrations of 
galactolipids in the fruit (Christensen, 2009; Kharazmi, 2008). In clinical 
studies, rose hip powder has been found to reduce the pain of osteoarthritis 
(Christensen et al., 2008; Rossnagel et al., 2007) and to provide moderate 
benefits for patients with rheumatoid arthritis and chronic back pain (Willich et 
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al., 2010; Chrubasik et al., 2008). Furthermore, rose hips have been shown to 
possess hypoglycaemic effects in diabetic rats and to produce a modest 
lowering of total cholesterol in humans, which supports the traditional use in 
Turkey of rose hips to treat diabetes (Orhan et al., 2009; Rein et al., 2004). A 
standardised rose hip (Rosa canina L.) powder produced in Denmark has been 
on the market as an herbal remedy in the Scandinavian area for many years and 
is also readily available in Australia and New Zealand (Cohen, 2012; Winther, 
2008). 
Besides interest in the anti-inflammatory activity, studies on the anti-cancer 
activity of rose hips have increased in recent years. Rose hip extract has been 
found to decrease the proliferation of human glioblastoma cell lines A-172, U-
251 MG, and U-1242 MG, human cervix epithelial cancer cell line HeLa, 
human breast cancer cell line MCF-7 and human colon cancer cell line HT-29, 
effects which have mainly been attributed to the polyphenols and the abundant 
carotenoid constituents (Cagle et al., 2012; Tumbas et al., 2012; Olsson et al., 
2004). 
1.2 Carotenoids 
Carotenoids are one of the dominant phytochemical groups in rose hips. The 
concentration of carotenoids can reach 1 mg/g dry weight in ripe rose hips, 
which is two-fold and eight-fold higher than the concentration reported for 
flavonoids and phenolics in rose hips, respectively. The carotenoid content in 
rose hips is much higher than that in many other fruits and berries, including 
cherry, raspberry, blueberry, blackcurrant, plum, and apple (Andersson et al., 
2011; Olsson et al., 2004). 
1.2.1 Structural properties of carotenoids 
Carotenoids, which are also called tetraterpenoids, include all derivatives of 
tetraterpenes. Carotenoids have a long conjugated double chain formed by 
eight isoprene units. Natural carotenoids exist either in free form or in 
esterified form. The free form carotenoids are classified as carotenes (which 
are purely hydrocarbons and contain no oxygen), for example lycopene, α- and 
β-carotene, and xanthophylls (which contain oxygen), for example 
violaxanthin, lutein, and zeaxanthin (Figure 2). Due to the existence of the 
hydroxyl group, xanthophylls can be esterified with fatty acids to form 
xanthophyll esters. 
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Figure 2. Chemical structure of isoprene, β-carotene (an example of a carotene), lutein (an 
example of a xanthophyll), and lutein dimyristate (an example of a xanthophyll ester). 
The conjugated polyene chromophore determines the light absorption 
properties, the natural yellow to red colour, the photochemical properties of the 
molecule, and consequently the photo-protective action in the original 
organism (Britton, 1995a). Carotenoids have special finger-shaped absorbance 
spectra in the 400-500 nm wavelength range (Britton, 1995b). Each individual 
spectrum can be defined by the wavelength of the middle absorption band 
(λmax) and a numerical notation %III/II, describing the fine structure (Figure 3). 
1.2.2 Health effects of carotenoids  
Epidemiological studies have shown that increased dietary intake of 
carotenoids reduces the risk of coronary heart disease in men (Liu et al., 2001) 
and women (Osganian et al., 2003) and decreases the risk of cardiovascular 
disease mortality (Gaziano et al., 1995). In elderly men, total plasma 
carotenoid level can be a health indicator due to its negative association with 
mortality risk (Akbaraly et al., 2009).                      
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Figure 3. A representative spectral fine structure of lycopene. %III/II is calculated for each 
individual carotenoid (Britton, 1995b). 
The relationship between carotenoids and different types of cancers has also 
been widely investigated. A positive correlation between plasma carotenoid 
concentration and recurrence-free survival rate in women diagnosed with early-
stage breast cancer has been suggested (Rock et al., 2005). In a large case-
control study, lutein, but not other carotenoids, has been found to be inversely 
associated with colon cancer in both men and women (1993 cases, 2410 
controls) (Slattery et al., 2000). Moreover, plasma carotenoid level has been 
found to be inversely associated with the risk of cervical neoplasia (Potischman 
& Brinton, 1996) and β-carotene has been found to induce apoptosis in cervical 
dysplastic cells and prevent cervical carcinogenesis in in vitro studies (Muto et 
al., 1995). No association has been found between lung cancer risk and dietary 
lycopene or β-cryptoxanthin intake, whereas dose-dependent inverse 
associations have been found for dietary β-carotene, α-carotene, and lutein. No 
other carotenoid, but high intake of lycopene, has been found to be associated 
with a 35% lower risk of total prostate cancer and a 53% lower risk of 
advanced prostate cancer (Giovannucci, 2002). All these studies indicate the 
specificity of the anti-cancer properties of different carotenoids in multiple 
cancer types. Therefore, consuming fruit and vegetables containing various 
carotenoids, compared with only foods rich in a particular carotenoid, is 
suggested for a healthy life. 
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1.3 Triterpenes 
Triterpenes are constructed of six isoprene units, which can build nearly 200 
different skeletons (Xu et al., 2004). Triterpenes are one of the most diverse 
groups of plant natural products, with more than 20,000 compounds reported to 
date. Triterpenes are components of surface waxes, which accumulate in the 
epicuticular and intracuticular wax layers of stem and leaf surfaces (Buschhaus 
et al., 2007). 
Triterpenes can be classified into different groups according to their 
biosynthetic pathways. These include the squalene, lanostane, dammarance, 
lupane, oleanane, ursane, and hopane groups, and a miscellaneous group (Hill 
& Connolly, 2012). Ursolic acid (UA) (belonging to the ursane group), 
oleanolic acid (OA) (belonging to the oleanane group), and betulinic acid (BA) 
(belonging to the lupane group) are representative pentacyclic triterpenes (Hill 
& Connolly, 2012). Their chemical structures are shown in Appendix 1 in 
Paper IV.  
Ursolic acid concentration has been found to range from 60 to 100 mg per 
100 g of fresh matter in cranberry fruit (Kondo, 2006) and UA has also been 
isolated from blueberry fruit (Wang et al., 2000). Oleanolic acid is the most 
abundant constituent of grape wax (Radler & Horn, 1965). Both UA and OA 
are present in sweet cherry fruit wax and in apple peel (Lv et al., 2015; Peschel 
et al., 2007). A considerable amount of BA is found in the outer bark of a 
variety of tree species, especially the birch tree (Yogeeswari & Sriram, 2005). 
These three triterpenes have all been detected in rose hips, with UA 
constituting 80% of the total triterpene content in Rosa canina L. (Wenzig et 
al., 2008), while OA, UA, and BA are approximately equally distributed in 
Rosa multiflora Thunb. (Paper IV).  
Triterpenes have a wide range of applications in the food, cosmetics and 
pharmaceutical industries (Thimmappa et al., 2014). White birch bark, 
containing BA, is used by Native Americans as a folk remedy and is used in 
tea and other beverages to treat stomach and intestinal problems such as 
diarrhoea and dysentery (Yogeeswari & Sriram, 2005). Both OA and UA, and 
their derivatives, have well-documented anti-inflammatory (Li et al., 2003), 
anti-ulcer (Nishino et al., 1988), hepatoprotective (Udayama et al., 1998), anti-
diabetic (Ortiz-Andrade et al., 2007), fungicidal (Becker et al., 2005) and anti-
parasitic (Cunha et al., 2003) effects. Anti-cancer activity of OA, UA, and BA 
has been reported for a wide variety of cancer cell lines (Shyu et al., 2010; 
Srivastava et al., 2010; Petronelli et al., 2009). It has also been found that 
inhibition of growth and metastasis of human colorectal cancer cell lines by 
UA can be enhanced in combination with capcetabine (Prasad et al., 2012). A 
triterpene extract (containing OA, UA, and BA) from Japanese apricot has 
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been reported to show synergistic cytotoxicity in oesophageal squamous 
carcinoma cells (YES-2 cells) when combined with the anticancer drug 5-
fluorouracil, causing apoptosis and inhibiting metastasis in a mouse model 
(Yamai et al., 2009). These studies reveal potential to enhance anti-cancer 
activity by combining triterpenes with other anti-cancer compounds. 
1.4 Ascorbate (vitamin C) 
Ascorbate/ascorbic acid/vitamin C is the most abundant antioxidant in plant 
tissues (Walker et al., 2006). It is an important nutrient for normal metabolic 
functions in humans. Deficiency of ascorbate can lead to various symptoms of 
scurvy (Padh, 1991). Ascorbate plays an important protective role in the body 
against damage by free radicals through its free radical scavenging ability and 
contributes to protection of cellular membranes against lipid peroxidation and 
damage to DNA and cellular organelles (Bendich et al., 1986). Rose hips are 
an ascorbate-rich resource. The ascorbate content in rose hips is much higher 
than many other fruits and berries (Olsson et al., 2004), e.g. it can be up to 47.5 
mg/g in the richest samples from the species Rosa cinnamomea L. and Rosa. 
acicularis Lindl. (Pyke & Melville, 1942). 
Besides the well-known antioxidant properties, high doses of ascorbate 
exhibit pro-oxidant properties, through interaction with metal ions, catalysing 
their oxidation with concomitant formation of H2O2 (Chen et al., 2008; Fisher 
& Naughton, 2004). Cancer cells are more susceptible to increased oxidative 
stress by ATP depletion than normal cells. Primary ATP generation in normal 
cells occurs through oxidative phosphorylation, but in cancer cells glycolysis 
may play a major role (the Warburg effect) (López-Lázaro, 2008). It has been 
suggested that H2O2 decreases glycolysis in cancer cells and that the 
mitochondria are more sensitive to H2O2, resulting in decreased ATP 
production. Cancer cells that are specifically glycolysis-dependent could be 
particularly sensitive to H2O2 compared with normal cells (Chen et al., 2007). 
Therefore, high doses of ascorbate have been used in pro-oxidative therapeutic 
strategies in cancer treatment (Venturelli et al., 2015).  
In humans taking ascorbate orally, the resulting plasma concentration rarely 
exceeds 80 µM, even up to 2000 mg per day is ingested (Levine et al., 1996). 
In Sweden the recommended daily intake of ascorbate for adult is 75 mg per 
day (SLV, 2017). In Sweden, therefore the ascorbate concentrations showing 
cytotoxicity in cancer cells in culture (mM) can only be achieved by 
intravenous administration to patients (Verrax & Calderon, 2009). 
Furthermore, parenterally administered ascorbate (≈0.25-0.5 mg/g body 
weight) has been shown to preferentially generate Asc•- and H2O2 in the 
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extracellular fluid but not in blood, which has been suggested to provide a 
foundation for pursuing ascorbate treatment in cancer therapy (Chen et al., 
2007).  
A previous study reported a positive correlation between the level of vitamin 
C and the anti-proliferative effect of 10 extracts from different fruits and 
berries in the HT29 human colon cancer cell line and in the MCF-7 human 
breast cancer cell line (Olsson et al., 2004). Lately, it has been found that 
ascorbate improves the therapeutic efficacy of gemcitabine in human 
pancreatic cancer cell lines (Espey et al., 2011) and acts synergistically with 
sorafenib in killing hepetocellular carcinoma HepG2 cells, but not in primary 
hepatocytes (Rouleau et al., 2016). This thesis examined the ability of different 
combinations of carotenoids, ascorbate, and triterpenes to yield synergistic 
effects in cancer treatment.  
1.5 Human breast cancer and cell lines 
Breast cancer originates from breast tissue. Some breast cancers start in the 
ducts where milk is transported to the nipple (ductal cancers), while other 
breast cancers have their origin in the glands where the breast milk is generated 
(lobular cancers) (Sariego et al., 1995). The hormones oestrogen and 
progesterone promote breast cancer growth and a positive association has been 
found between increased risk of breast cancer and sex hormone concentrations 
in both pre-menopausal (Hormones & Group, 2013) (Key et al., 2013) and 
post-menopausal women (Hankinson et al., 1998). Men can also contract 
breast cancer, but it is about 100-fold more common in women than in men 
(Hotko, 2013). 
Breast cancer is the most frequent carcinoma in women (Lux et al., 2006). 
Worldwide, 1.7 million new cases were diagnosed in 2012 and the breast 
cancer death rate is higher than that for any other cancer apart from lung 
cancer. The chance of a woman dying from breast cancer is about 3% (Torre et 
al., 2015). Breast cancer is staged from 0 to IV/(4) according to the size of the 
tumour, whether it has grown into nearby areas, whether it has reached the 
lymph nodes and whether it has metastasised (American Cancer Society, 
2016). The five-year survival rate is 99% for diagnosed early-stage breast 
cancer patients, but only 23% for advanced-stage patients. The recurrence rate 
five and ten years after treatment is 11% and 29%, respectively (Brewster et 
al., 2008).  
The heterogeneity of breast cancer has been noted in histological and 
clinical studies for a long time. Breast cancer is one of the few cancer types 
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that has so far been subjected to molecular classification for individual therapy, 
which has significantly improved the clinical outcome (Polyak, 2011).  
Figure 4. Schematic representation of normal breast tissue (American Cancer Society, 2016). 
 
1.5.1 Breast-derived cell lines  
Breast cancers can be classified into different sub-groups according to 
receptors that exist in the cell membrane, cytoplasm, and nucleus, which bind 
chemical messengers and induce reactions in cells. The most important 
receptors for breast cancer classification are hormone receptors (including 
oestrogen and progesterone receptors) and human epidermal growth factor 
receptor 2 (HER2) (Vuong et al., 2014). Hormone receptor-positive cancers, 
which are more common in women after the menopause, can be treated with 
hormonal therapy drugs that decrease oestrogen levels or block oestrogen 
receptors (Pusztai et al., 2006). Hormone receptor-negative cancers, which are 
more common in women before the menopause, can be classified into HER2-
positive cancer or triple-negative cancer (cells do not have oestrogen and 
progesterone receptors or HER2 receptor) (American Cancer Society, 2016). 
Clinically, the prognosis for patients with HER2 tumours is poorer than that for 
patients with oestrogen receptor-positive tumours and triple-negative cancer is 
correlated with a worse prognosis and a higher risk of death (Liu et al., 2013).  
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In the present thesis, the two human breast cancer cell lines MCF-7 and 
JIMT-1 were chosen for testing due to their representative characteristics for 
different breast cancer sub-groups. In addition, the human breast-derived MCF-
10A cell line was used as a normal-like cell model for comparison.  
JIMT-1 (Figure 5A) is a human ductal carcinoma breast cancer cell line 
established from a pleural metastasis in a 62-year-old female patient in 2004 
(Tanner et al., 2004). The JIMT-1 cells lack expression of oestrogen and 
progesterone receptors and overexpress HER2 mRNA and protein, therefore 
are classified into the HER2 sub-group of breast cancers. However, JIMT-1 
cells are insensitive to HER2-inhibiting antibodies, for instance trastuzumab, 
pertuzumab, and lapatinib (Köninki et al., 2010; Tanner et al., 2004). The 
JIMT-1 cell line is phenotypically of epithelial progenitor cell origin, with a 
doubling time of about 24 hours. 
Figure 5. Phase contrast images of the human breast cancer cell lines (A) JIMT-1 and (B) MCF-7, 
and (C) the human normal-like breast epithelial cell line MCF-10A. Bars = 20 µM. Photos: L. 
Zhong. 
MCF-7 (Figure 5B) is a human breast cancer cell line established from the 
pleural effusion of a 69-year-old female patient with metastatic mammary 
carcinoma in 1972 (Soule et al., 1973). MCF-7 is an oestrogen-positive cell 
line and has proven to be an excellent model for studying the mechanism of 
tumour response to endocrine therapy and the biological actions of hormones 
(Levenson & Jordan, 1997; Horwitz et al., 1975). The doubling time of the 
MCF-7 cell line is about 35 hours. 
MCF-10A (Figure 5C) is a normal-like breast epithelial cell line derived 
from human diploid fibrocystic mammary tissue and has been maintained as an 
attached immortal cell line since 1990 (Soule et al., 1990). It has been used for 
studying the mechanism of breast epithelium transformation and in many 
breast cancer therapy research studies as a normal-like breast epithelial cell 
model (Ramachandran et al., 2005; Davis et al., 2000; Tannheimer et al., 1998; 
Ginestra et al., 1997; Soule et al., 1990).  
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1.5.2 Cancer stem cells 
Since the first discovery of leukaemia stem cells about a decade ago (Dick, 
1997), attention has been drawn to a cell sub-population now also found in 
solid tumours that has similar properties to somatic (tissue-specific) stem cells. 
This cell population has been named tumour-initiating cells or cancer stem 
cells (CSCs) (Kai et al., 2010). The latter definition is used in this thesis. Like 
normal tissue-specific stem cells, CSCs possess self-renewal and 
differentiation abilities, through symmetrical and asymmetrical division, 
respectively (Figure 6). The microenvironment of the CSCs, which is termed 
the CSC ‘niche’, is believed to maintain the properties of CSCs (Reya et al., 
2001). During recent years, CSCs have been recognised as important targets 
for cancer treatments (Dragu et al., 2015). 
Figure 6. Cancer stem cells (CSCs) and their self-renewal and differentiation abilities, which 
maintain the hierarchical structure of cancer tissue (Kai et al., 2010).  
The suggestion that only a minority of breast cancer cells have the ability to 
form new tumours was initially put forward by Ai-Hajj et al. (2003). Breast 
cancer cells are heterogeneous with respect to expression of various types of 
cell surface markers. The same investigation done by Ai-Hajj et al. found that 
the tumour-forming sub-population or the CSC sub-population had increased 
expression of CD44 and reduced or absent expression of CD24 on the cell 
membrane (CD44+/CD24-/low). This sub-population was found to be highly 
tumorigenic compared with other phenotypes (Al-Hajj et al., 2003). Later, 
aldehyde dehydrogenase (ALDH), an enzyme family that catalyses 
dehydrogenation of aldehydes, was found to be expressed in a sub-population 
of human normal breast cells and this sub-population was found to have 
phenotypic and functional characteristics of mammary stem cells (Ginestier et 
al., 2007). Furthermore, the ALDH+ population has been shown to contain a 
number of up-regulated stem cell-related genes. The presence of ALDH+ has 
also been shown to be a good marker for CSC sub-population identification 
(Charafe-Jauffret et al., 2009).  
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Despite the fact that diagnostics and therapeutic treatment for cancer have 
achieved significant improvements, metastasis still results in about 90% of 
cancer deaths and is the major cause of cancer mortality (Christofori, 2006; 
Hanahan & Weinberg, 2000). Clinically, therapeutic agents that inhibit tumour 
metastasis are highly desirable. Metastasis is a multistep process through which 
a primary tumour moves from its initial site to secondary tissues or organs 
(Fidler, 2003; Weiss, 1999). In 2007, it was suggested that the CSCs might be 
primarily responsible for tumour metastasis (Dalerba et al., 2007). The 
relationship between CSCs and tumour metastasis has been investigated in 
pancreatic cancer and it has been shown that the CSC sub-population is 
essential for this process (Dalerba & Clarke, 2007; Hermann et al., 2007). One 
of the essential steps in tumour metastasis is cell migration and invasion, 
through which tumour cells can enter the lymphatic system and blood vessels 
and thereby spread into secondary organs (Steeg, 2006; Mareel & Leroy, 
2003).  
Some studies have shown that overexpression of HER2 receptors in a series 
of breast cancer cell lines increases the ALDH+ CSC sub-population, with 
increased expression of stem cell regulatory genes, increased invasion and 
increased tumorigenesis in mice (Korkaya et al., 2008). HER2-positive cell 
lines are specially enriched in a distinct CSC sub-population defined by 
ALDH+ (Lesniak et al., 2013). The JIMT-1 cell line, the first commercially 
established HER2-positive cell line, contains a rather large proportion of cells 
with ALDH activity and it is used as a model for CSC studies in cell culture 
studies.  
1.5.3 Nuclear factor-B pathway  
Many therapeutic agents exert their activity against cancer cells by affecting 
various complex signal transduction pathways. The nuclear factor-κB (NF-κB) 
pathway was initially identified as a regulator in B lymphocytes nearly 30 
years ago and has been examined extensively in cancer therapy studies. NF-κB 
is a family of proteins consisting of five members, p50, p52, p65 (RelA), RelB, 
and c-Rel, forming homo- and heterodimers, which are responsible for 
activating transcription of target genes for immunoregulation, inflammation, 
proliferation, and cell differentiation (Yamamoto et al., 2013; Hayden & 
Ghosh, 2008). When not active, NF-κB is sequestered in the cytoplasm by 
association with inhibitory proteins. When triggered by stimuli, NF-B dimers 
are released and translocated to the nucleus, where they bind to specific DNA 
sequences and promote the transcription of target genes (Hayden & Ghosh, 
2008).  
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In normal cells, NF-κB becomes activated only under appropriate stimuli 
and afterwards returns to the bound inactive state, while in cancer cells it may 
be constitutively activated due to dysregulation, resulting in impaired 
regulation of gene expression (Dolcet et al., 2005). Thus, the NF-κB pathway 
is a target for therapeutic intervention and thus for drug development.  
It has been reported that the NF-κB pathway is important for leukaemia stem 
cells (Guzman et al., 2005; Malaguarnera et al., 2003; Guzman et al., 2001) 
and that the CSC sub-population of breast cancers can be selectively inhibited 
by targeting the NF-κB pathway (Yamamoto et al., 2013; Zhou et al., 2008). In 
this thesis, the NF-κB pathway was investigated as a mechanism of action of 
some compounds that showed inhibition of the CSC sub-population.  
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2 Aims and objectives  
 
The overall aims of this thesis were to: 1) determine the carotenoid 
composition of rose hips from different species; 2) investigate the anti-
proliferative activities of different carotenoid fractions and single carotenoid 
compounds; 3) explore the effects of selected carotenoid fractions and single 
carotenoids on breast cancer cells and on the CSC sub-population and elucidate 
the mechanism; and 4) investigate the combined effect of different 
phytochemicals on cancer cell proliferation. 
 
Specific objectives were to: 
 Develop a simple, rapid, and efficient HPLC-DAD-APCI+-MS method 
for identifying and quantifying the carotenoid composition in rose hips 
from different rose species (Paper I) 
 Investigate the anti-proliferative activity of various carotenoid 
fractions in rose hips from different rose species in human breast 
cancer cell lines (Paper II) 
 Compare the anti-proliferative activity of xanthophylls and 
xanthophyll esters on human breast cancer cell lines (Paper III) 
 Investigate the inhibitory effect of the most effective carotenoid ester 
fraction and individual xanthophyll esters on the CSC sub-population 
and elucidate the mechanism (Papers II and III) 
 Investigate the combined anti-proliferative effect of carotenoids, 
triterpenes and ascorbate in cancer cells and normal-like cells (Paper 
IV). 
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The hypotheses tested were that: 
 Carotenoid composition and concentration vary between rose species 
(Paper I) 
 Anti-proliferative activity varies between carotenoid fractions, rose 
species, and cancer cell lines (Paper II) 
 Xanthophyll esters are more potent inhibitors of cell proliferation than 
xanthophylls (Paper III) 
 The carotenoid ester fraction from rose hips and individual 
xanthophyll esters inhibit the CSC sub-population, partly through the 
NF-κB pathway (Papers II and III) 
 The combined effect of carotenoids, triterpenes, and ascorbate on cell 
proliferation varies between different combinations of compounds, 
concentrations, and different cell lines (Paper IV) 
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3 Materials and methods 
The procedures used in the analyses are described briefly below. Detailed 
information on all methods can be found in Papers I-IV. 
3.1 Plant materials 
Five rose species were used in this study: Rosa rubiginosa L. (Figure 7A), 
Rosa carolina L. (Figure 7B), Rosa multiflora Thunb. (Figure 7C), Rosa 
virginiana P. Mill (Figure 7D), and Rosa rugosa Thunb. (Figure 7E). Rose hips 
from plants of these five species growing in Alnarpsparken (55°39’N, 
13°04’E), Swedish University of Agricultural Sciences, Alnarp, Sweden, were 
used in the experiments. Fruit harvesting was carried out at the fully ripe stage 
in the late harvest season, defined according to a previous study (Andersson et 
al., 2011), in order to obtain high carotenoid levels. Rose hips were picked 
from two to three bushes for each species and pooled (Figure 7). All samples 
were stored at -80 °C immediately after harvest until extraction.  
Rose hips from R. rubiginosa, R. multiflora, R. virginiana, and R. rugosa 
harvested in autumn 2014 were used in Paper I. Rose hips from R. rubiginosa, 
R. carolina, R. multiflora, R. virginiana, and R. rugosa harvested in autumn 
2013 were used in Paper II and rose hips from R. multiflora harvested in 
autumn 2014 were used in Paper IV. 
     Marigold (Tagetes erecta L.) flowers were grown in the greenhouse at the 
Swedish University of Agricultural Sciences, Alnarp, Sweden. Fresh flower 
petals were harvested and used for extraction of lutein dimyristate (Paper III) 
and lutein myristate palmitate (Paper II).  
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Figure 7. Photos showing how the size and colour of rose hips differ between species: (A) R. 
rubiginosa, (B) R. carolina, (C) R. multiflora, (D) R. virginiana, and (E) R. rugosa. Bar at right 
bottom corner of each picture = 1 cm. Photos: L. Zhong. 
3.1.1 Dry sample extraction  
In general, plant materials for analysis were first freeze-dried, milled, and 
homogenised. A fixed amount of rose hip powder or marigold petal powder 
was extracted with an adequate amount of ethanol/n-hexane (v/v, 4/3), hexane, 
or ethanol depending on the objective (Table 1). After 30 min ultrasonication 
and 20 h shaking at 4 °C in darkness, the extract was centrifuged at 3000 g at 4 
°C for 10 min. When carotenoid fractions were isolated, around 1 mL 
supernatant was saved for quantification. The other part was dried under N2 
and dissolved in tetrahydrofuran (THF) for carotenoid fraction isolation and in 
ethanol for triterpene fraction (TF) isolation. 
3.1.2 Fresh sample extraction  
Fresh marigold petals were used for extraction in Paper II. A 30 g portion of 
fresh petals was homogenised in 200 mL methanol/ethyl acetate/petroleum 
ether (v/v/v, 1/1/1). After 1 h shaking, the upper phase was collected. The 
extraction was conducted three times in total. About 20 mg of anhydrous 
sodium sulphate (Na2SO4) were added to the extract to absorb the remaining 
water. After centrifugation, the supernatant was dried under N2 and dissolved 
in 100 μL THF for isolation. 
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Table 1. Extraction methods used for different purposes in Papers I-IV 
Purpose Plant material Solvent Paper  
Carotenoid identification 
and quantification 
0.5 g rose hip powder 10 mL ethanol/n-hexane 
(v/v, 4/3)  
I 
Carotenoid fraction 
isolation 
1.5 g rose hip powder 15 mL ethanol/n-hexane 
(v/v, 4/3)  
II 
Lutein ester isolation 1.5 g marigold petal 
powder 
30 mL hexane III, IV 
Triterpene quantification 
and fraction isolation 
5 g rose hip powder 50 mL ethanol 
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3.1.3 Saponification  
In Paper I, the samples were subjected to saponification to determine the 
xanthophyll composition of the rose hips. In brief, 500 µL of 10% (w/v) KOH 
in methanol:water (4:1, v/v) solution and 200 mg butylated hydroxytoluene 
were added slowly to 5 mL carotenoid extract under N2. After 45 min at 75 °C, 
5 mL of 2% (w/v) KCl and 5 mL n-hexane/ethyl acetate (9:1, v/v) were added. 
The sample was then centrifuged at 3000 g for 5 min to obtain the upper 
organic layer. Extraction after saponification was conducted three times in 
total. The supernatant was dried under N2 and dissolved in 5 mL acetone. 
3.2 Identification, quantification and isolation of carotenoid 
fractions/compounds 
3.2.1 Identification and quantification of carotenoids in rose hips and 
procedure for isolation 
A high-performance liquid chromatograph equipped with a diode array 
detector and an atmospheric pressure chemical ionisation (positive mode) mass 
spectrometer (HPLC-DAD-APCI+-MS) was used for carotenoid identification 
and quantification in Paper I. HPLC-DAD was used for carotenoid 
quantification and fraction isolation in Paper II. 
A Phenomenex Luna column (3 µ, 100 × 3 mm C18 (2)) with a C18 
security guard column was used for identification and quantification and a 
Phenomenex Luna column (5 μ, 150 × 4.60 mm C18) with a C18 security 
guard column was used for isolation of fractions. Different elution gradients 
consisting of solvent A [80% acetonitrile, 15% methanol, and 5% 
dichloromethane (v/v/v)] and solvent B [30% acetonitrile, 20% methanol, and 
50% dichloromethane (v/v/v)] were used according to the purpose of the 
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analysis. Detection of carotenoids was always carried out at a wavelength of 
458 nm. 
In Paper I, each carotenoid compound was identified through a combination 
of absorption spectrum and MS signals. In addition, the fatty acid composition 
was analysed by gas chromatography (GC). In Paper II, carotenoid fractions 
were identified and the lycopene isomer fraction, undefined carotene fraction 
and xanthophyll ester fraction were isolated mainly according to their elution 
sequence. All carotenoid compounds or fractions were quantified with β-
carotene as external standard. 
3.2.2 Isolation of lutein esters from marigold petals 
Lutein dimyristate and lutein myristate palmitate isolation was carried out with 
a semi-preparative Phenomenex Luna column (10 µ, 250 × 10.00 mm C18) 
with a C18 security guard column. The eluent consisted of 50% acetonitrile, 
18% MeOH and 32% dichlormethane (v/v/v). Flow rate was 5 mL/min for 80 
min. Lutein dimyristate was isolated between the 27th and 31st min (Figure 2A 
in Paper III) and lutein myristate palmitate was isolated between the 34th and 
38th min (Figure S1 in Paper II). 
3.3 Quantification of triterpenes and isolation of the triterpene 
fraction 
Separation and subsequent quantification of triterpenes in rose hips were 
conducted using an YMC Triart C18 ExRS plus column (3 µm, 150 x 3.0 mm, 
8 nm). Triterpene fraction isolation was carried out with a VYDAC column. 
Compounds were eluted using 100% acetonitrile and detected at 207 nm 
wavelength. External standards of UA, OA, and BA were used for 
quantification (Paper IV). 
3.4 Chemical synthesis of zeaxanthin dimyristate  
The synthesis procedure was based on a previous study (Khachik & Beecher, 
1988). Zeaxanthin dimyristate was produced by esterification of zeaxanthin 
and myristoyl chloride under N2 as atmosphere in limited light. The target 
product was isolated and purified using solid phase chromatography.  
Both lutein dimyristate and zeaxanthin dimyristate were quantified using 
HPLC, with an Agilent Eclipse Plus C18 column (3.5 µm, 3.0 x 100 mm). The 
eluent consisted of 40% acetonitrile, 19% methanol, and 41% dichloromethane 
(v/v/v) with 1 mL/min flow rate for 5 min. β-Carotene was used as external 
standard (Paper III). 
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3.5 Cell culture conditions 
The two human breast cancer cell lines JIMT-1 and MCF-7 were used in Paper 
II and the human breast epithelial normal-like cell line MCF-10A was used in 
addition in Papers III and IV. All cell lines were cultured in their individual 
formulation of medium. The cells were incubated at 37 °C in a humidified 
atmosphere of 5% CO2 in air. The JIMT-1 and MCF-10A cells were routine-
passaged twice a week and the MCF-7 cells once a week.  
When adding compounds, carotenoids and triterpenes were always first 
dissolved and diluted to a stock in phosphate-buffered saline (PBS) with 0.1% 
Tween 80. When compounds or fractions were added to the cell culture 
medium to the desired concentration, the final concentration of Tween 80 in 
the cell culture medium was no higher than 0.01%, a non-toxic concentration 
for cells (Figure S2 in Paper II). In Paper IV, a stock ascorbate solution was 
made fresh in PBS every time just before use.  
3.6 MTT assay  
A tetrazolium compound, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT) assay was used in this thesis. The MTT assay has 
been widely adopted as a 96-well format cell proliferation indicator in 
thousands of published articles, based on the simplicity of the protocol. Cells 
of different cell lines were seeded in 96-well plates in 180 µL medium and 
incubated for 24 h, and then 20 µL of compound in different concentrations 
were added to the cells (Figure 8A). After 72 h of incubation, a MTT solution 
was added to the cells.  
Figure 8. Example of a MTT assay in a 96-well plate. (A) Plate image at 24 h after seeding, when 
compound was added at increasing concentrations from row 4 to row 11. (B) MTT was reduced to 
formazan by the living cells and the formazan crystals were dissolved in dimethyl sulphoxide 
(DMSO), producing a purple solution. The letter B written on the plates means background (row 
1), C means control (rows 2 and 3), and T1 and T2 mean different treatments (rows 4 to 11). 
Photos: L. Zhong. 
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Living cells reduce MTT to purple formazan (Mosmann, 1983) in the 
mitochondrial electron transport chain and the absorbance of the purple 
formazan at 540 nm reflects the number of living cells (Figure 8B). The 
formazan crystals were dissolved in dimethyl sulphoxide (DMSO) and the 
absorbance of the solution was monitored in a spectrophotometer. Dose 
response curves were drawn and concentration giving 50% inhibition (IC50) 
was obtained using the Graphpad software (Papers II, III, and IV). 
3.7 Cancer stem cell population ALDH+ assay  
JIMT-1 cells were seeded in Petri dishes and incubated for 24 h. Compounds 
were added and cells were then incubated for 72 h. The cells were detached 
with AccutaseTM and collected in PBS containing 1% foetal calf serum (FCS). 
The cell density was determined by counting in a haemocytometer and a 
ALDEFLUOR assay kit was used to determine the number of ALDH+ cells 
according to the protocol in a previous study (Huang et al., 2016) (Papers II 
and III). 
3.8 Cell migration assay  
JIMT-1 cells were seeded to achieve high density in Petri dishes. After 24 h 
incubation, the medium was removed and three parallel wounds were made in 
the cell layer by scratching. To minimise wound healing resulting from cell 
proliferation, serum-free medium was added and then the compounds were 
added before continued incubation. The wound area was photographed using a 
10x objective in an inverted phase contrast microscope at 0, 24, and 48 h of 
incubation. The wound area was measured using Image J software and wound 
closure was calculated (Papers II and III). 
3.9   Nuclear factor-B translocation assay  
JIMT-1 cells were seeded in 12-well plates containing a round glass cover slip 
in each well. The medium was replaced with medium containing 0.1% FCS 
after 48 h of incubation. Compounds were added and incubation continued for 
1 h, after which tumour necrosis factor-α (TNF-α) was added and incubation 
continued for 40 min. The cells were then fixed with 3.7% formaldehyde. 
Blocking buffer was used to block nonspecific binding sites and to 
permeabilise the cells. Rabbit anti-p65/NF-κB primary antibody and Alexa 488 
anti-rabbit-conjugated secondary antibody were then added sequentially to the 
samples, with the incubation time with each antibody being 1 h. Thereafter, the 
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cover slips were mounted in Mowiol on slides and the cells were observed 
using a 100x objective in an epifluorescence microscope. Images were taken 
and the number of NF-κB positive cells was determined by manual counting in 
the images (Papers II and III). 
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4 Results and discussion 
4.1  HPLC-DAD-APCI+-MS method development and 
carotenoid identification  
One of the aims of this thesis was to develop an adequate HPLC-DAD-APCI+-
MS method for the identification and quantification of carotenoids in rose hips. 
A simple, rapid method was established on the basis of a previous HPLC-DAD 
method (Andersson et al., 2011) on a short 100 x 3 mm reverse phase C18 
column with 0.8 mL/min gradient elution for 22 min for each sample. An APCI 
was fitted in the MS detector and positive mode was chosen to identify 
xanthophyll esters. In addition, the total lipid composition of rose hips was 
determined in the process, to investigate the fatty acid part of the esterified 
xanthophylls using GC (Table 2 in Paper I).  
The changes in the chromatograms of carotenoids before and after 
saponification reflected the xanthophylls that existed in ester form in rose hips 
(Figure 1 in Paper I). Xanthophyll and carotene identification was based on the 
elution sequence, retention time of the peaks and individual absorbance spectra 
parameters, including λmax, %III/II (Britton, 1995a; Britton, 1995b) and 
%AB/AII (the ratio of the cis peak absorbance (AB) to the middle peak 
absorbance (AII)) (Goupy et al., 2013; Britton, 1995b). In MS analysis, 
xanthophylls usually lose one or two H2O molecules, resulting in [M+H-18]+ 
or [M+H-18-18]+ fragments, respectively. The abundance of the MS signal 
fragments also provides information on molecular structure difference, for 
instance lutein and zeaxanthin isomers (Delgado-Pelayo & Hornero-Méndez, 
2012) (Table 1 in Paper I).  
Identification of xanthophyll esters was based on the combination of 
absorption spectrum obtained from the DAD detector and the protonated 
molecular mass [M+H]+ and molecular fragments obtained from the MS 
detector. Xanthophyll esters losing one molecule of capric acid (C10:0), lauric 
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acid (C12:0), myristic acid (C14:0) or palmitic acid (C16:0) resulted in [M+H-
172]+, [M+H-200]+, [M+H-228]+ or [M+H-256]+ fragments, respectively, in 
MS signalling (Table 3 in Paper I).  
Eleven xanthophylls and 10 carotenes were detected in the saponified 
extract from rose hips and 23 xanthophyll esters were detected in the 
unsaponified extract from rose hips. 
4.2 Carotenoid content in rose hips  
To better describe and compare the carotenoid content in rose hips, in this 
thesis the carotenoids were divided into five groups: xanthophylls, lycopene 
isomers, undefined carotenes, β-carotene, and xanthophyll esters (Figure 1 in 
Paper II). As shown in Figure 9, lycopene isomers, undefined carotenes, and 
xanthophyll esters were the dominant carotenoids in rose hips. The β-carotene 
concentration was relatively stable between species and years. Around 80-90% 
of the xanthophylls were esterified and were present as xanthophyll esters in 
rose hips harvested during the late season in this thesis.  
Figure 9. Carotenoid concentration (µg/g dry weight) in rose hips from five rose species collected 
during 2013 and 2014.  
The carotenoid content in rose hips differed between species and years. The 
total carotenoid content in rose hips from R. carolina and R. virginiana reached 
1.7 mg/g dry weight, which was much higher than that in rose hips from R. 
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rubiginosa, R. multiflora, and R. rugosa. In general, fruits from 2013 contained 
slightly higher amounts of carotenoid than fruits from 2014 except for R. 
virginiana. This difference was assumed to reflect the different climate 
conditions between these two years, where the summer temperature in 2014 
was somewhat warmer than in 2013 and the total number of sunshine hours in 
June, July, and August 2014 was greater than in 2013 (SMHI, 2013 & 2014). 
The rose hips were harvested based on their colour and ripening time was 
approximately one week earlier in 2014 than in 2013. The total carotenoid 
content was lower in 2014 than in 2013, which was correlated to a decrease in 
either the lycopene fraction or the undefined carotene fraction (Figure 9). 
Similarly, Andersson et al. (2011) demonstrated that the content of lycopene 
and total carotenoids in rose hips has a significant negative correlation with 
temperature and irradiation, which confirms the influence of climate on the 
variation in carotenoid content in rose hips between years. Interestingly, even 
though the total carotenoid content in rose hips in 2014 was generally lower 
than in 2013, the xanthophyll ester content was increased for four rose species 
out of five. These differences could be related to the carotenoid synthesis 
mechanism in plants as a reaction to external environmental stimuli or stress.  
4.3 Anti-proliferative effects of carotenoids, triterpenes, and 
ascorbate  
4.3.1 Anti-proliferative effects of different carotenoid fractions from rose hips  
In Paper II, the anti-proliferative effects of the total carotenoid extract (TCE) 
and different carotenoid fractions from rose hips, including the lycopene 
isomer fraction, undefined carotene fraction, and xanthophyll ester fraction, 
were investigated in the two human breast cancer cell lines JIMT-1 and MCF-
7. The IC50 was used as a parameter for evaluation and comparison of anti-
proliferative activity. 
As shown in Figures 2 and 3 in Paper II, the xanthophyll ester fraction 
showed similar anti-proliferative activity to TCE and was obviously more 
potent than the lycopene isomer and undefined carotene fractions, as evidenced 
by single-digit µg/mL IC50 values in most cases (Table 2 in Paper II). Both 
TCE and the xanthophyll ester fraction from R. multiflora hips showed higher 
anti-proliferative activity than those from the other species. Interestingly, the 
xanthophyll ester composition in rose hips from R. multiflora was found to be 
different from that in hips from the other species. As reported in Paper I, the 
dominant peaks of the xanthophyll ester fraction in R. multiflora were lutein 
dilaurate (C12:0-C12:0), zeaxanthin dilaurate (C12:0-C12:0), and a relatively 
high proportion of violaxanthin dilaurate (C12:0-C12:0), while in the other 
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species the dominant peaks were rubixanthin laurate (C12:0) and rubixanthin 
myristate (C14:0).  
Anti-cancer activity of other terpenoid esters, but not of xanthophyll esters, 
has been reported. A sesquiterpene ester extracted from the root of Celastrus 
orbiculatus has been found to reverse the multi-drug resistance property of 
MCF-7/ADR cells and human oral epidermal cancer KB-V1 cells (Kim et al., 
1998). Five daphnane diterpene esters extracted from Daphne genkwa 
(Thymelaeaceae) flowers have been found to inhibit the proliferation of A549 
human lung cancer cells, but to be relatively non-cytotoxic in normal lung 
epithelial MRC-5 cells (Hong et al., 2010). Isolated UA hydroxycinnamate 
esters can inhibit the proliferation of several lung, colon, breast, and renal 
cancer cell lines, as well as melanoma and leukaemia cell lines with 1.2 to 11 
μM IC50 values (Kondo, 2006). To investigate the anti-proliferative activity of 
xanthophyll esters, MTT assays were used in Papers II and III. The anti-
proliferative activity of the free xanthophylls lutein and zeaxanthin and their 
respective esters were compared in Paper III. 
In Paper III, neither lutein nor zeaxanthin showed any inhibitory effect in 
cell proliferation up to a concentration of 100 µM (Figure 3A in Paper III). 
Lutein and zeaxanthin have been reported to inhibit human oral epithelial 
cancer KB cells after 72 h of incubation, with IC50 values of 50 µM and 30 
µM, respectively (Sun & Yao, 2007). Thus, the same compounds have 
different effects on different cell types. Both lutein dimyristate (Figure 3B in 
Paper III) and lutein myristate palmitate (Figure 4 in Paper II) resulted in IC50 
values in the single-digit µM range and zeaxanthin dimyristate resulted in IC50 
values in the single- to double-digit µM range (Table 2). It was therefore 
confirmed that the xanthophyll esters were significantly more potent than their 
respective free xanthophyll forms.  
 
Table 2. IC50 values (µM) of xanthophylls and xanthophyll esters obtained in MTT assay using the 
JIMT-1 and MCF-7 human breast cancer cell lines and the MCF-10A normal-like human breast 
epithelial cell line 
1 Lutein dimyristate. 
2 Lutein myristate palmitate. 
3 Zeaxanthin dimyristate. 
4 Not investigated. 
Compound  JIMT-1 MCF-7 MCF-10A 
  
Lutein ˃ 100 ˃ 100 ˃ 100   
Zeaxanthin ˃ 100 ˃ 100 ˃ 100   
Lu-C14-C141 2.25 ± 0.40 0.85 ± 0.16 2.32 ± 0.48   
Lu-C14-C162 6.34 ± 0.14 2.19 ± 0.48 NI4   
Zea-C14-C143 ~ 50 6.80 ± 0.95 18.28 ± 6.30   
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In addition, the cell proliferation data showed that lutein esters were more 
potent than zeaxanthin esters and that lutein dimyristate was more potent than 
lutein myristate palmitate. This suggests that the xanthophyll component, as 
well as the fatty acid component, in the xanthophyll ester structure influence 
the bioactivity of the compounds. Further investigations are needed to increase 
understanding of the difference in bioactivity of various xanthophyll esters.  
Comparison with reported IC50 values for conventional breast cancer 
chemotherapy drugs such as mitoxantrone (0.34 µM), chlorambucil (3.4 µM), 
cyclophosphamide (6.6 µM), doxorubicin (9.6 µM), cis-platinum (14 µM), and 
5-fluorouracil (28 µM) in MCF-7 cells, and with liposomal-delivered 
doxorubicin in JIMT-1 cells (59 µM) after 72 h treatment (Tan et al., 2010; 
Mahoney et al., 2003), indicates that the two lutein diesters investigated have a 
more potent anti-proliferative activity than all except mitoxantrone. Although 
the data obtained from cell lines of xanthophyll ester treatments are thus 
interesting, many more preclinical studies are needed before these compounds 
can be considered as chemotherapeutic drugs for clinical trials.  
Xanthophyll esters are believed to be hydrolysed by hydroxyl ester lipases 
in the gut before being taken up by the intestinal mucosal cells and esters are 
not normally found in blood (Zaripheh & Erdman, 2002). For example, 
Wingerath et al. (1995) showed that an increased amount of free β-
cryptoxanthin was present in chylomicrons and serum, but no ester, after intake 
of a β-cryptoxanthin ester-enriched tangerine concentrate. On the other hand, 
xanthophyll esters have been detected in human skin at a low level (pmol/g 
human skin) after intake of tangerine juice concentrate (Wingerath et al., 
1998). Moreover, lutein esters (3% of the total serum lutein content) have been 
found in serum after food supplementation with a natural source of lutein 
mixture (extract from marigold flower) (Granado et al., 1998), suggesting 
probable re-esterification of xanthophylls following absorption. Furthermore, 
human CaCo-2 cells have been found to be able to esterify xanthophylls 
(Sugawara et al., 2009). However, due to the hydrolysis of xanthophyll esters 
in the gut and the low ratio of re-esterification of xanthophylls in the human 
body, xanthophyll esters administered orally will presumably not result in 
serum concentrations that are inhibitory to cancer cells. The clinical 
chemotherapeutic drugs used nowadays for breast cancer treatment are 
typically given either through injection or infusion (American Cancer Society, 
2016). A functional concentration of xanthophyll esters could possibly be 
achieved by parenteral administration.   
Even though chemotherapy is one of the most efficient treatment modalities 
applied in clinical oncology, severe side-effects are usually associated with it, 
resulting in different degrees of damage to tissues and organs (Ratajczak et al., 
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2013). Thus, chemotherapeutic drugs with a low degree of side-effects are 
needed. In this context, it must be pointed out that the xanthophyll esters were 
also toxic to the normal-like MCF-10A cells tested in this thesis. However, it 
should also be noted that the oestrogen receptor-positive MCF-7 cells were 
more sensitive to the esters than the other two cell lines. The implications of 
this observation need further investigation.   
4.3.2 Anti-proliferative effects of combinations of lutein dimyristate, triterpenes, 
and ascorbate  
Both triterpenes and ascorbate have been reported to have synergistic anti-
cancer effects in many cancer cell lines in combination with other compounds 
(Rouleau et al., 2016; Prasad et al., 2012; Espey et al., 2011; Yamai et al., 
2009; Olsson et al., 2004). Therefore ascorbate and triterpenes (OA, UA, BA, 
and TF from R. multiflora hips) and the xanthophyll ester lutein dimyristate 
were used in combination in Paper IV. 
When the compounds or TF were added to cells singly, the anti-
proliferative activity found differed as follows: ascorbate ˂ BA ˂ OA ˂ UA ˂ 
TF ˂ lutein dimyristate (Table 1 in Paper IV). 
Among the combinations of lutein dimyristate and various triterpenes 
tested, the IC50 of lutein dimyristate combined with 10 or 50 µM triterpenes 
resulted in synergistic effects mostly in the MCF-7 cell line. For some 
combinations, antagonistic effects were seen in JIMT-1 cells, while the MCF-
10A normal-like cells were less sensitive (Figure 1 in Paper IV). A 
combination of 10 µM TF and 0.025 ̴ 0.1 mM ascorbate (in particular 50 µM 
ascorbate) was found to be the most promising combination, inhibiting the 
proliferation of MCF-7 cancer cells without influencing the MCF-10A cells 
(Figure 2 in Paper IV).  
Previous studies have demonstrated that a high oral dose of ascorbate has no 
benefit in overall survival of cancer patients (Moertel et al., 1985; Creagan et 
al., 1979) and that the ascorbate concentration inducing cytotoxicity in cancer 
cells can only be achieved by intravenous administration (Verrax & Calderon, 
2009). However, 50 M ascorbate, which when administered together with 10 
µM TF resulted in a synergistic effect in MCF-7 breast cancer cells, could 
easily be obtained by a daily ascorbate oral intake of 100 mg (Levine et al., 
1996). Thus, the data obtained in this thesis suggest that an oral dose of 
ascorbate could enhance the toxicity of certain therapeutic compounds in 
cancer treatment.  
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4.4 Inhibitory effects of carotenoids on cancer stem cell ALDH+ 
population  
ALDH enzyme activity is a CSC sub-population marker in breast cancer 
(Charafe-Jauffret et al., 2009) and JIMT-1, a HER2-positive cell line, contains 
a distinct CSC sub-population defined by ALDH+ (Huang et al., 2016; Lesniak 
et al., 2013). One of the characteristics of CSCs is their innate resistance to 
chemotherapy-induced cell death, which is called multiple drug resistance 
(MDR) (Eyler & Rich, 2008). CSCs express high levels of ATP-binding 
cassette transporters which mediate drug efflux, resulting in increased 
resistance to conventional chemotherapeutic drugs such as paclitaxel, 
doxorubicin, 5-fluorouracil, and cisplatin (Dean et al., 2005; Hirschmann-Jax 
et al., 2004). This MDR property of CSCs allows them to survive and initiate 
tumour recurrence, impeding efficacious cancer treatment (Donnenberg & 
Donnenberg, 2005; Kessel et al., 1968). Therefore drugs targeting CSCs are 
required. In this thesis, the effects of the xanthophyll ester fraction isolated 
from R. multiflora hips and of xanthophyll esters on CSCs were investigated 
by monitoring the ALDH+ sub-population in the JIMT-1 cell line (Table 3).  
In Papers II and III, the ester fraction and all xanthophyll esters studied were 
found to significantly reduce the CSC sub-population defined by ALDH+ cells 
compared with the control. Treatments with IC50 of the ester fraction or lutein 
myristate palmitate reduced the CSC population by almost 50% i.e. in the same 
range as the total cell number reduction in the MTT assay.  
 
Table 3. Effect of treatment with xanthophyll ester fraction or xanthophyll esters in reducing the 
ALDH+ sub-population in JIMT-1 cells. Values are presented as percentage of control value. 
 Compound       IC₂₅       IC₅₀ 
Ester fraction 85.7 ± 7.7   55.0 ± 19.3   
Lu-C14-C141 88.1 ± 8.4   84.6 ± 13.6   
Lu-C14-C162 79.8 ± 13.7  53.2 ± 20.5   
Zea-C14-C143 64.2 ±14.8 80.5 ± 12.4  
1 Lutein dimyristate. 
2 Lutein myristate palmitate. 
3 Zeaxanthin dimyristate. 
4.5 Inhibitory effects of carotenoids on cell migration  
Metastasis is the major cause of cancer mortality, resulting in about 90% of 
cancer deaths (Christofori, 2006; Hanahan & Weinberg, 2000). It has been 
reported that CSCs are responsible for cancer metastasis (Dalerba & Clarke, 
2007; Hermann et al., 2007). Cell migration is one of the most important steps 
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in cancer metastasis (Steeg, 2006; Mareel & Leroy, 2003). One method using 
cell lines to investigate effects of compounds on cell migration is the wound 
healing assay (Zahm et al., 1997). After scratching of the monolayer, the cell-
cell contact is disrupted and the cells at the wound margin start healing the 
wound through proliferation and migration (Zahm et al., 1997; Coomber & 
Gotlieb, 1990). To limit the effect resulting from cell proliferation, serum-free 
medium was used in the wound healing assay in this thesis.  
Wound closure was decreased to different extents by treatment with the 
ester fraction isolated from R. multiflora hips and the xanthophyll esters at 
concentration giving 25% inhibition (IC25) or IC50 (Figure 10, see also Figure 
5A in Paper II and Figure 4A in Paper III), but not by lutein or zeaxanthin 
treatment at a concentration of 20 M (data not shown). Compared with the 
control, treatment with the ester fraction or xanthophyll esters resulted in 
significant inhibition of cell migration 24 h after scratching (except lutein 
dimyristate) and 48 h after scratching (except lutein dimyristate and IC25 of 
zeaxanthin dimyristate) (statistics are shown in Figure 5B in Paper II and in 
Figure 4B in Paper III).  
Figure 10. Effects of treatments on wound closure. Treatments: IC25 and IC50 of the ester fraction 
isolated from R. multiflora hips, lutein dimyristate (Lu-C14-C14), lutein myristate palmitate (Lu-
C14-C16), and zeaxanthin dimyristate (Zea-C14-C14). 
The xanthophyll esters investigated in this thesis, especially lutein myristate 
palmitate, significantly inhibited cell migration at the concentrations reducing 
the number of cells. Interestingly, lutein myristate palmitate treatment reduced 
the ALDH+ population more efficiently than lutein dimyristate treatment, 
which might have been reflected in the wound healing assay. 
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4.6 Inhibition of TNF--induced NF-κB translocation to the 
nucleus by xanthophyll esters 
TNF-α is a pleotrophic polypeptide cytokine which plays a significant role 
primarily in immune activities by activating the transcription factor NF-κB 
(Feuerstein et al., 1993). When not active, NF-κB is sequestered in the 
cytoplasm by inhibitory proteins. TNF-α treatment induces phosphorylation of 
the inhibitory proteins, which results in release of NF-κB. Free NF-κB 
translocates from the cytoplasm to the nucleus to start regulating the 
transcription of various proteins important for cell proliferation and 
inflammatory responses (Beg & Baltimore, 1996; Baeuerle & Henkel, 1994).  
In Papers II and III, the effects of the xanthophyll ester fraction isolated 
from R. multiflora hips and of other xanthophyll esters on TNF-α-induced NF-
κB translocation to the nucleus were investigated. Representative images are 
shown in Figure 6A in Paper II and in Figure 6A in Paper III. In this assay, 
TNF-α treatment alone resulted in 96% of nuclei becoming NF-κB positive. 
After 1 h of treatment with IC50 of the ester fraction or the xanthophyll esters 
before TNF-α treatment, both lutein dimyristate and the ester fraction slightly 
reduced the number of NF-κB-positive nuclei. However, lutein myristate 
palmitate treatment reduced the number of NF-κB-positive nuclei to 35% 
(Figure 11). On increasing the treatment time of lutein dimyristate to 4 h 
instead of 1 h before adding TNF-α, the number of NF-κB-positive nuclei 
decreased to 82% (compared with 90% after 1 h pre-treatment) (Figure 6 in 
Paper III). Treatment with IC50 of zeaxanthin dimyristate for 4 h decreased the 
number of positive nuclei to 21% (Figure 6 in Paper III). Previous studies have 
reported that emodin and curcumin inhibit TNF-α-induced NF-κB translocation 
in a dose-dependent manner (Plummer et al., 1999; Kumar et al., 1998), while 
the results in this thesis show that time is also important.  
Nuclear factor-B is an important transcription factor involved in CSC 
maintenance and is a promising target in cancer therapy, especially in targeting 
the CSC population (Liu et al., 2010; Murohashi et al., 2010; Zhou et al., 
2008). The xanthophyll esters studied in this thesis have been proven to partly 
react in cancer cells through the NF-κB pathway, but this pathway is complex, 
with regulatory steps on different levels (Gilmore & Herscovitch, 2006) and 
more detailed studies are required to better understand the targets of 
xanthophyll esters in this pathway. The findings in this thesis provide a general 
direction for further mechanistic studies on xanthophyll esters in breast cancer 
treatment.  
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Figure 11. Inhibition of TNF--induced NF-κB translocation to the nucleus by 1 h treatment with 
IC50 of ester fraction isolated from R. multiflora hips, lutein dimyristate (Lu-C14-C14), and lutein 
myristate palmitate (Lu-C14-C16).  
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5 Conclusions and future perspectives  
The main conclusions of this thesis are as follows. 
 
 A simple and efficient HPLC-DAD-APCI+-MS method was 
developed for identification and quantification of carotenoids in 
rose hips. Twenty-one carotenoids, including 11 xanthophylls and 
10 carotenes, were detected in saponified extract and 23 carotenoid 
esters in unsaponified extract of rose hips from five different rose 
species. 
 
 The carotenoid content in rose hips differed between species and 
years. Lycopene, undefined carotene, and xanthophyll esters were 
dominant carotenoid components in rose hips. The highest 
carotenoid content, 2.3 mg/g dry weight, was found in Rosa 
carolina L. hips in 2013. 
 
 A lower IC50 value in the human breast cancer cell lines JIMT-1 
and MCF-7 in MTT assay was found for xanthophyll ester fraction 
than for lycopene isomer and undefined carotene fractions. The 
xanthophyll ester fraction from Rosa multiflora Thunb. hips was 
more potent than that in hips from the other species tested, which 
may be attributable to the unique xanthophyll ester composition of 
R. multiflora, which includes lutein dilaurate, zeaxanthin dilaurate, 
and violaxanthin dilaurate. 
 
 Xanthophyll esters were more potent in cell proliferation inhibition 
than their respective free xanthophyll forms, in both cancer cell 
lines and a normal-like cell line.  
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 The xanthophyll ester fraction isolated from Rosa multiflora 
Thunb. hips and the xanthophyll esters lutein dimyristate, lutein 
myristate palmitate, and zeaxanthin dimyristate were found to 
decrease the ALDH+ CSC sub-population and inhibit cell 
migration. 
 
 The xanthophyll esters partly exerted their effects through 
inhibiting the NF-κB pathway. 
 
 Synergistic and antagonistic effects in cell proliferation inhibition 
were found in MCF-7 and JIMT-1 cell lines, respectively, when 
lutein dimyristate was combined with triterpenes. The best 
combination effect was found when an orally viable serum 
concentration of ascorbate (50 µM) was combined with 10 µM TF 
isolated from Rosa multiflora Thunb. hips. This combination 
significantly inhibited the MCF-7 cancer cell line without affecting 
the normal-like MCF-10A breast epithelial cells.  
 
 
In future investigations on natural compounds in rose hips and xanthophyll 
esters, there are many openings to pursue. These include: 
 
 Studying the mechanism of carotenoid synthesis in rose hips, 
especially the esterification procedure, and further exploring the 
difference between species from a genetic perspective. This could 
be useful if carotenoid content and composition are included as 
considerations in future rose hip breeding. 
 
 Testing the bioactivity of other phytochemicals, for example 
phenolic compounds, in rose hips in order to explore their 
nutritional role. 
 
 Defining the contribution of OA, UA, and BA to the synergistic 
effect of combinations of ascorbate and TF and investigating other 
anti-cancer activities of this combination for possible development 
as chemotherapeutic agents. 
 
 Investigating and comparing the anti-cancer effect of xanthophyll 
esters constructed from different xanthophylls (e.g. violaxanthin 
esters) and different fatty acids (e.g. lutein dilaurate, zeaxanthin 
dilaurate), in order to gain a better understanding of molecular 
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structure and toxicity. The toxicity in normal cells should always 
be taken into consideration.  
 
 Investigating other cancer types regarding the effect of xanthophyll 
esters, e.g. pancreatic cancer, which is especially treatment-
resistant with a dismal outcome.  
 
 Exploring more detailed mechanisms of the NF-κB pathway and 
investigating the nature of the specific protein or process targeted 
by the compounds. This would help to further utilise xanthophyll 
esters in cancer therapy. 
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